Key Takeaways

  • Rosie O’Donnell attributes her health improvement to the GLP-1 drug Mounjaro.
  • She experienced weight gain after her mother’s death in 1973.
  • O’Donnell has lost weight steadily over the past three years while on the medication.
  • Other celebrities have shared mixed experiences with GLP-1 drugs.

O’Donnell’s Journey with Mounjaro

Rosie O’Donnell has credited the GLP-1 medication Mounjaro with significantly improving her life. In a recent interview, she reflected on her struggles with weight gain following the death of her mother, Roseann O’Donnell, in 1973. O’Donnell shared that the loss affected her and her siblings deeply, leading to unhealthy eating habits during their childhood.

Childhood Memories and Weight Struggles

O’Donnell recalled how, as children, they would shop for groceries with a $100 bill given by their father. She noted that at just 11 years old, shopping for a family of five meant choosing less nutritious options. “It was Entenmann’s and Cap’n Crunch,” she said, explaining how they would often have to put back healthier items to stay within budget. The grief they experienced as a family contributed to their weight gain.

Impact of Mounjaro

Since starting Mounjaro, O’Donnell has reported losing a pound or two each month over the past three years. She expressed a desire to promote the drug, wishing that the price could be lowered for those struggling with obesity. “I know the shame that we carry and the humiliation that is dealt to people who are overweight,” she stated.

Reflections on Body Image

The 64-year-old actress also opened up about her past concerns regarding body image, particularly during her appearances on late-night shows. She admitted that her focus was often on how she looked rather than her performance. “When I would do late night, my biggest concern wasn’t my set, it was, did I look fat?” she recalled.

Mixed Experiences with GLP-1 Drugs

O’Donnell’s positive experience with Mounjaro contrasts with some other celebrities who have shared their challenges with GLP-1 medications. Mayim Bialik recently described severe side effects, including uncontrollable diarrhea and cramping. Similarly, Jenny Mollen reported complications while using a GLP-1 drug, including heavy bleeding and fainting spells.

Despite the varied experiences, O’Donnell emphasized her improved health and sense of empowerment, stating that she feels “much healthier and more powerful” now.